Using the online tool KM Plotter, we see that TBX2 mRNA expression (as evaluated using 4 different probesets) correlated (significantly in most instances) with poor outcomes in ERα breast cancers and within the Triple Negative Breast Cancer (TNBC) subtype (Supplementary Figure S12). This evidence concerns the gene ESR1 and breast carcinoma.